High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
TripAdvisor (NASDAQ:TRIP) reported second-quarter results in line with its expectations as growth in its experiences business was offset by persistent search-related pressure in legacy offerings and uneven travel demand. The company also said it expects to complete the sale of restaurant reservation
NAVI's Q2 results benefit from lower expenses and provisions, lifting EPS above estimates. Shares gain 4.8% despite lower NII and other income.
(Bloomberg) -- The Pentagon aims to conduct the first tests for its futuristic space-based missile defense program by yearend, with flight demonstrations of the unproven technology slated for 2027, people familiar with the matter said.Most Read from BloombergOpenAI’s New Device Will Be Hockey Puck-Sized and Cost Over $300Iran Wants to Bar US, Israeli Ships From Hormuz in Peace AccordIran Says Agreement on Hormuz Shipping Reached With OmanTrump Administration Considers Order on Autism and Vaccine
Although the revenue and EPS for Solaris Energy Infrastructure, Inc. (SEI) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
While the top- and bottom-line numbers for Sunrun (RUN) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
MTZ's record Q2 revenues, 40% EBITDA growth and $21.4B backlog underpin its raised 2026 outlook despite Communications delays.
Can the Nasdaq's tech-led rally continue in 2H 2026? Here are the key catalysts, risks and ETFs to watch.
CNC, DAR, GD, FCEL and CC stocks show how women-led companies are redefining growth with discipline, agility and results.
Ford Motor has told car dealers it intends to produce a four-door, gas-powered version of the Mustang for the first time, adding a variant to the “pony car” that has sold in the millions since 1964, according to people familiar with the matter. It could go on sale before the close of this decade and resembles the current two-door Mustang, one of the people said. “We do not comment or speculate about future products,” a Ford spokesman said.
Dutch Bros' stock is being punished, but its actual operations remain stronger than ever.
Natera and Halozyme Therapeutics saw gains above 15%, led by bullish Wall Street commentary after better-than-expected second-quarter results.
RGTI's Q2 revenues surge 185.3% and beat estimates, but widening losses and higher R&D and SG&A costs continue to pressure profitability.
HIMS' second-quarter 2026 results are likely to benefit from weight-loss demand and global expansion even as margin pressures and higher spending linger.
TNA has handed short-term traders a spectacular ride, but the five-year chart tells a story that most leveraged ETF investors never stick around long enough to read.
Financial stocks were lower in Friday afternoon trading, with the NYSE Financial Index down 0.1% and
The quantum computing stock could head even higher over the next few years.
Zuckerberg is underwriting a multiyear compounding story.
Whatnot’s cofounders had trouble impressing investors before building the live-shopping app.
State Street disclosed a passive stake of 7.3% in Redwire, according to a 13G filing on Friday.
Energy stocks were lower Friday afternoon, with the NYSE Energy Sector Index decreasing 0.5% and the
Okta stock has surged over 70% in 2026 as AI-based "agents" that perform tasks on the internet require new cybersecurity safeguards.
Bank of America's CEO said the company spends more than $250 million a year on GLP-1 drugs for employees, calling the growing cost a worthwhile investment.
The data mining and AI specialist continued its rapid rebound.
Rockstar Energy founder Russ Savage now holds over 12 million shares of Celsius (CELH), or about 4.7
The live commerce platform's valuation has nearly doubled since its $11.5 billion Series F round last October
Prothena beat adjusted Q2 loss estimates, reaffirmed 2026 cash-use guidance and highlights partner pipeline progress as a key milestone decision nears.
Trupanion's Q2 earnings beat estimates as revenue rose 11%, while premium valuation and muted analyst sentiment support a wait-and-see approach.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
